1 - 25 of 2
Number of results to display per page
TitleCreatorDescriptionIdentifier
1 Introduction and Lessons from Vigabatrin (abstract)Rod ForoozanIt is often difficult to determine the validity of reported toxicity attributed to a drug and a neuro-ophthalmic abnormality. In some cases, the patient has received combination therapy, such as surgical resection and medical therapy, and in other cases, the complications are not the focus of the re...20170406_nanos_nosideeffects1_01-abstract
2 Introduction and Lessons from Vigabatrin (video)Rod ForoozanVigabatrin was introduced as an anti-seizure medication in the United Kingdom in 1989 and was extensively used until 1997 when concerns for peripheral visual field defects emerged. When the drug was approved in the United States in 2009 it carried a black box warning for the risk of permanent visual...20170406_nanos_nosideeffects1_01-video
1 - 25 of 2